» Articles » PMID: 39334476

Validating the Splicing Effect of Rare Variants in the SLC26A4 Gene Using Minigene Assay

Overview
Publisher Biomed Central
Specialty Genetics
Date 2024 Sep 28
PMID 39334476
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The SLC26A4 gene is the second most common cause of hereditary hearing loss in human. The aim of this study was to utilize the minigene assay in order to identify pathogenic variants of SLC26A4 associated with enlarged vestibular aqueduct (EVA) and hearing loss (HL) in two patients.

Methods: The patients were subjected to multiplex PCR amplification and next-generation sequencing of common deafness genes (including GJB2, SLC26A4, and MT-RNR1), then bioinformatics analysis was performed on the sequencing data to identify candidate pathogenic variants. Minigene experiments were conducted to determine the potential impact of the variants on splicing.

Results: Genetic testing revealed that the first patient carried compound heterozygous variants c.[1149 + 1G > A]; [919-2 A > G] in the SLC26A4 gene, while the second patient carried compound heterozygous variants c.[2089 + 3 A > T]; [919-2 A > G] in the same gene. Minigene experiments demonstrated that both c.1149 + 1G > A and c.2089 + 3 A > T affected mRNA splicing. According to the ACMG guidelines and the recommendations of the ClinGen Hearing Loss Expert Panel for ACMG variant interpretation, these variants were classified as "likely pathogenic".

Conclusions: This study identified the molecular etiology of hearing loss in two patients with EVA and elucidated the impact of rare variants on splicing, thus contributing to the mutational spectrum of pathogenic variants in the SLC26A4 gene.

References
1.
Albert S, Blons H, Jonard L, Feldmann D, Chauvin P, Loundon N . SLC26A4 gene is frequently involved in nonsyndromic hearing impairment with enlarged vestibular aqueduct in Caucasian populations. Eur J Hum Genet. 2006; 14(6):773-9. DOI: 10.1038/sj.ejhg.5201611. View

2.
Danilchenko V, Zytsar M, Maslova E, Posukh O . Selection of Diagnostically Significant Regions of the Gene Involved in Hearing Loss. Int J Mol Sci. 2022; 23(21). PMC: 9655724. DOI: 10.3390/ijms232113453. View

3.
Tian Y, Xu H, Liu D, Zhang J, Yang Z, Zhang S . Increased diagnosis of enlarged vestibular aqueduct by multiplex PCR enrichment and next-generation sequencing of the SLC26A4 gene. Mol Genet Genomic Med. 2021; 9(8):e1734. PMC: 8404235. DOI: 10.1002/mgg3.1734. View

4.
Pera A, Dossena S, Rodighiero S, Gandia M, Botta G, Meyer G . Functional assessment of allelic variants in the SLC26A4 gene involved in Pendred syndrome and nonsyndromic EVA. Proc Natl Acad Sci U S A. 2008; 105(47):18608-13. PMC: 2584577. DOI: 10.1073/pnas.0805831105. View

5.
Yuan Y, You Y, Huang D, Cui J, Wang Y, Wang Q . Comprehensive molecular etiology analysis of nonsyndromic hearing impairment from typical areas in China. J Transl Med. 2009; 7:79. PMC: 2754984. DOI: 10.1186/1479-5876-7-79. View